Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2018 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
Lee JV, Housley F, Yau C, Nakagawa R, Winkler J, Anttila JM, Munne PM, Savelius M, Houlahan KE, Van de Mark D, Hemmati G, Hernandez GA, Zhang Y, Samson S, Baas C, Kok M, Esserman LJ, van 't Veer LJ, Rugo HS, Curtis C, Klefström J, Matloubian M, Goga A. Lee JV, et al. Among authors: baas c. Nat Commun. 2022 Jun 27;13(1):3671. doi: 10.1038/s41467-022-31238-y. Nat Commun. 2022. PMID: 35760778 Free PMC article.
Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials.
DuRoss AN, Phan J, Lazar AJ, Walker JM, Guimaraes AR, Baas C, Krishnan S, Thomas CR Jr, Sun C, Bagley AF. DuRoss AN, et al. Among authors: baas c. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1867. doi: 10.1002/wnan.1867. Epub 2022 Oct 28. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 36308008 Review.
New Horizons in Advocacy Engaged Physical Sciences and Oncology Research.
Samson S, Northey JJ, Plaks V, Baas C, Dean I, LaBarge MA, Goga A, Van't Veer LJ, Weaver VM. Samson S, et al. Among authors: baas c. Trends Cancer. 2018 Apr;4(4):260-264. doi: 10.1016/j.trecan.2018.02.002. Epub 2018 Mar 15. Trends Cancer. 2018. PMID: 29606307 Free PMC article. Review.
Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
Lee JV, Housley F, Yau C, Nakagawa R, Winkler J, Anttila JM, Munne PM, Savelius M, Houlahan KE, Van de Mark D, Hemmati G, Hernandez GA, Zhang Y, Samson S, Baas C, Kok M, Esserman LJ, van 't Veer LJ, Rugo HS, Curtis C, Klefström J, Matloubian M, Goga A. Lee JV, et al. Among authors: baas c. Nat Commun. 2022 Nov 21;13(1):7140. doi: 10.1038/s41467-022-34570-5. Nat Commun. 2022. PMID: 36414627 Free PMC article. No abstract available.
Advocates' perspective: neoadjuvant chemotherapy for breast cancer.
Perlmutter J, Axler S, Baas C, Beckwith BJ, Bonoff A, Brain S, Delapine M, Devine M, Frank E, Fraser V, Gallece M, Geoghegan C, Hamade H, Heditsian D, Hirschhorn B, Kandell S, Laxague D, Lestage B, Lyzen M, Madden D, Mertz SA, Parker BJ, Roach N, Sauers N, Vincent L, Waddell D, Wetzel M, Wright K. Perlmutter J, et al. Among authors: baas c. J Clin Oncol. 2012 Dec 20;30(36):4586-8; author reply 4588-9. doi: 10.1200/JCO.2012.44.1824. Epub 2012 Nov 19. J Clin Oncol. 2012. PMID: 23169512 No abstract available.
Interventions to reduce cancer screening inequities: the perspective and role of patients, advocacy groups, and empowerment organizations.
Richardson-Parry A, Baas C, Donde S, Ferraiolo B, Karmo M, Maravic Z, Münter L, Ricci-Cabello I, Silva M, Tinianov S, Valderas JM, Woodruff S, van Vugt J. Richardson-Parry A, et al. Among authors: baas c. Int J Equity Health. 2023 Jan 27;22(1):19. doi: 10.1186/s12939-023-01841-6. Int J Equity Health. 2023. PMID: 36707816 Free PMC article.
Integrating pain metrics into oncology clinical trials.
Cleeland CS, O'Mara A, Zagari M, Baas C. Cleeland CS, et al. Among authors: baas c. Clin Cancer Res. 2011 Nov 1;17(21):6646-50. doi: 10.1158/1078-0432.CCR-11-1109. Clin Cancer Res. 2011. PMID: 22046026